Effects of tunicamycin on preimplantation mouse embryos: prevention of molecular differentiation during blastocyst

Developmental Biology
|November 1, 1985
PubMed

Insights

Carbohydrate molecules in early mouse embryos are crucial for development. Tunicamycin treatment blocked blastocyst formation and specific protein synthesis, highlighting their role in differentiation.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Glycobiology

Background:

  • Preimplantation mouse embryos rely on specific carbohydrate-containing molecules for early development.
  • Understanding these molecules' roles is key to deciphering developmental processes.

Purpose of the Study:

  • To investigate the function of carbohydrate-containing molecules in preimplantation mouse embryo development.
  • To analyze the molecular effects of tunicamycin on early embryonic development.

Main Methods:

  • Mouse embryos were cultured with tunicamycin (0.1 µg/ml) at different preimplantation stages.
  • Two-dimensional polyacrylamide gel electrophoresis was used to analyze protein expression.
  • The impact of tunicamycin and alpha-amanitin on mRNA and protein synthesis was assessed.

Main Results:

  • Tunicamycin inhibited blastocyst development and the synthesis of N-glycosidic glycoproteins and large polysaccharides.
  • Expression of blastocyst-specific proteins (BCPs) was significantly inhibited when treatment began before the 16-cell stage.
  • Tunicamycin's inhibitory effects on BCPs appeared specific, as most other proteins and bulk mRNA synthesis remained unaffected.

Conclusions:

  • Glycoproteins and large polysaccharides on morula-stage embryos are essential for morphological development.
  • These molecules play a critical role in triggering molecular-level differentiation during early embryogenesis.
  • The findings underscore the importance of glycosylation in developmental transitions.